|
|
 |
|
|
| Oxaliplatin |
| Manus Aktteva offers Oxaliplatin, 61825-94-3,for your RND & Pilots requirements with supportive technical package |
| Product Reference ID: MA-BO-79-D |
|
|
| Chemical Name: |
trans-L-Diaminocyclohexane oxalatoplatinum, Oxaliplatin |
|
|
| Description |
| CAS number |
61825-94-3 |
| Synonym |
Oxaliplatin, trans-L-Diaminocyclohexane oxalatoplatinum |
| Molecular Formula |
C8H12N2O4Pt |
| Molecular Weight |
395.27 |
| Specifications |
Specifications of Oxaliplatin avaialble on request
|
| Packing |
Export worthy packing |
Material Safety Data Sheet
|
MSDS of Oxaliplatin available on request
|
| Availability |
RND & Evaluation |
| Drug Master File |
Can be made available |
|
|
|
|
|
|
 Are you looking for Oxaliplatin Intermediates ? Please click here to browse through the list of Oxaliplatin Intermediates available with us. |
|
| Oxaliplatin, 61825-94-3,GMP, DMF, Drug Master File, suppliers, manufacturers, India, China |
|
|
|
|
 |
NOTE: 
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|